These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5547243)

  • 1. Hypercalcemia and neoplasia: a model system.
    Rice BF; Ponthier RL; Miller MC
    Endocrinology; 1971 May; 88(5):1210-6. PubMed ID: 5547243
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcaemia of neoplasia, parathyroid hormone and vitamin D: studies in parabiosis.
    Ponthier RL; Rice BF
    Acta Endocrinol (Copenh); 1974 Nov; 77(3):527-39. PubMed ID: 4370077
    [No Abstract]   [Full Text] [Related]  

  • 3. The hypercalcemic rat Leydig cell tumor--a model of the humoral hypercalcemia of malignancy.
    Sica DA; Martodam RR; Aronow J; Mundy GR
    Calcif Tissue Int; 1983 May; 35(3):287-93. PubMed ID: 6871760
    [No Abstract]   [Full Text] [Related]  

  • 4. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
    Gaich G; Burtis WJ
    Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal changes associated with hypertension in neoplasia-induced hypercalcemia.
    Sowers JR; Barrett JD
    Am J Physiol; 1982 May; 242(5):E330-4. PubMed ID: 7044141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.
    Berger ME; Golub MS; Sowers JR; Brickman AS; Nyby M; Troyer H; Rude RK; Singer FR; Horst R; Deftos LJ
    Life Sci; 1982 May; 30(18):1509-15. PubMed ID: 6281603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia and neoplasia. Biologic, biochemical, and ultrastructural studies of a hypercalcemia-producing Leydig cell tumor of the rat.
    Rice BF; Roth LM; Cole FE; MacPhee AA; Davis K; Ponthier RL; Sternberg WH
    Lab Invest; 1975 Oct; 33(4):428-39. PubMed ID: 52757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts.
    Troyer H; Sowers JR; Babich E
    Am J Pathol; 1982 Sep; 108(3):284-90. PubMed ID: 7114164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion.
    Spiegel AM; Saxe AW; Deftos LJ; Brennan MF
    Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.
    Insogna KL; Stewart AF; Vignery AM; Weir EC; Namnum PA; Baron RE; Kirkwood JM; Deftos LM; Broadus AE
    Endocrinology; 1984 Mar; 114(3):888-96. PubMed ID: 6546543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by Leydig cell tumor in thyroparathyroidectomized rats.
    Rizzoli R; Caverzasio J; Fleisch H; Bonjour JP
    Endocrinology; 1986 Sep; 119(3):1004-9. PubMed ID: 3755393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thyroparathyroidectomy in hypercalcemia associated with malignancy.
    Vogel SB; Enneking WF; Thomas WC
    Endocrinology; 1967 Mar; 80(3):404-8. PubMed ID: 6020212
    [No Abstract]   [Full Text] [Related]  

  • 14. Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.
    Colloton M; Shatzen E; Wiemann B; Starnes C; Scully S; Henley C; Martin D
    Eur J Pharmacol; 2013 Jul; 712(1-3):8-15. PubMed ID: 23623934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
    Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
    J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
    Henderson J; Bernier S; D'Amour P; Goltzman D
    Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of endogenous thyrocalcitonin for protection against hypercalcemia in the rat.
    Cooper CW; Hirsch PF; Munson PL
    Endocrinology; 1970 Feb; 86(2):406-15. PubMed ID: 5409935
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphologic and functional studies of a rat hypercalcemia-associated testicular tumor maintained in cell culture.
    Saxe AW; Santora A; Norton J; Triche T; Brennan MF; Spiegel A
    Surgery; 1985 Dec; 98(6):1013-23. PubMed ID: 3000012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of parathyroid hormone-related peptide production in vitro by the rat hypercalcemic Leydig cell tumor H-500.
    Liu B; Goltzman D; Rabbani SA
    Endocrinology; 1993 Apr; 132(4):1658-64. PubMed ID: 8462465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.